New combo tackles tough pancreatic cancer
Disease control
Completed
This phase 2 trial tested two drugs, cabozantinib and pembrolizumab, in 21 people with metastatic pancreatic cancer that had worsened after standard treatment. The goal was to see if the combination could slow cancer growth. The study is complete, and results may help guide futur…
Phase: PHASE2 • Sponsor: Joseph Kim • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC